BioAge Labs (Richmond, CA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases such as obesity, has announced the pricing …
Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at …
As healthcare systems embrace digital transformation, the increased reliance on connected devices, platforms, and remote work environments has significantly expanded …
Generate:Biomedicines has announced a multi-target collaboration with Novartis to develop protein therapeutics using its generative AI platform. The deal, valued …
Scientists from Aston University in Birmingham, led by Professor Richard Martin, have developed gallium-infused bioactive glass nanoparticles for treating osteosarcoma, …
ETH Zurich researchers have identified vortioxetine, an FDA-approved antidepressant, as a promising candidate in the fight against glioblastoma, a highly …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.